eSURFACE 1 and reSURFACE 2: Biological therapy improves psoriasis and CVD
In this MEDtalk, Professor Nehal Mehta presents very interesting results from the reSURFACE 1 and 2 regarding the association between psoriasis and CVD and how both conditions improve following biological therapy with tildrakizumab.